WEKO3
アイテム
{"_buckets": {"deposit": "c7c0ec51-9fe7-4348-8b86-902f4ad1e139"}, "_deposit": {"created_by": 1, "id": "84610", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "84610"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00084610", "sets": ["1"]}, "author_link": ["1021262", "1021261", "1021263", "1021256", "1021260", "1021269", "1021267", "1021265", "1021258", "1021268", "1021264", "1021259", "1021266", "1021257"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2022-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageStart": "101285", "bibliographicVolumeNumber": "15", "bibliographic_titles": [{"bibliographic_title": "Translational Oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "α-Sulfoquinovosylacyl-1,3-propanediol (SQAP) is a semi-synthetic derivative of natural sulfoglycolipid that sensitizes tumors to external-beam radiotherapy. How SQAP affects internal radiotherapy, however, is not known. Here, we investigated the effects of SQAP for radioimmunotherapy (RIT) targeting tissue factor (TF) in a stroma-rich pancreatic cancer mouse model, BxPC-3. A low dose of SQAP (2 mg/kg) increased tumor uptake of the 111In-labeled anti-TF antibody 1849, indicating increased tumor perfusion. The addition of SQAP enhanced the growth-inhibitory effect of 90Y-labeled 1849 without leading to severe body weight changes, allowing for the dose of 90Y-labeled 1849 to be reduced to half that when used alone. Histologic analysis revealed few necrotic and apoptotic cells, but Ki-67–positive proliferating cells and increased vascular formation were detected. These results suggest that the addition of a low dose of SQAP may improve the therapeutic efficacy of TF-targeted RIT by increasing tumor perfusion, even for stroma-rich refractory pancreatic cancer.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Elsevier"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "34839108", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1016/j.tranon.2021.101285", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.sciencedirect.com/science/article/pii/S193652332100276X?via%3Dihub", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1936-5233", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yoichi, Takakusagi"}], "nameIdentifiers": [{"nameIdentifier": "1021256", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aya, Sugyo"}], "nameIdentifiers": [{"nameIdentifier": "1021257", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Atsushi, Tsuji"}], "nameIdentifiers": [{"nameIdentifier": "1021258", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hitomi, Sudo"}], "nameIdentifiers": [{"nameIdentifier": "1021259", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasunaga, Masahiro"}], "nameIdentifiers": [{"nameIdentifier": "1021260", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsumura, Yasuhiro"}], "nameIdentifiers": [{"nameIdentifier": "1021261", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugawara, Fumio"}], "nameIdentifiers": [{"nameIdentifier": "1021262", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakaguchi, Kengo"}], "nameIdentifiers": [{"nameIdentifier": "1021263", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatsuya, Higashi"}], "nameIdentifiers": [{"nameIdentifier": "1021264", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoichi, Takakusagi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1021265", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aya, Sugyo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1021266", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Atsushi, Tsuji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1021267", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hitomi, Sudo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1021268", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatsuya, Higashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1021269", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/84610", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-08-24"}, "publish_date": "2021-08-24", "publish_status": "0", "recid": "84610", "relation": {}, "relation_version_is_last": true, "title": ["The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3"], "weko_shared_id": -1}
The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
https://repo.qst.go.jp/records/84610
https://repo.qst.go.jp/records/8461072625d29-f844-4ca3-9e6d-a858878d35a9
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-08-24 | |||||
タイトル | ||||||
タイトル | The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3 | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Yoichi, Takakusagi
× Yoichi, Takakusagi× Aya, Sugyo× Atsushi, Tsuji× Hitomi, Sudo× Yasunaga, Masahiro× Matsumura, Yasuhiro× Sugawara, Fumio× Sakaguchi, Kengo× Tatsuya, Higashi× Yoichi, Takakusagi× Aya, Sugyo× Atsushi, Tsuji× Hitomi, Sudo× Tatsuya, Higashi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | α-Sulfoquinovosylacyl-1,3-propanediol (SQAP) is a semi-synthetic derivative of natural sulfoglycolipid that sensitizes tumors to external-beam radiotherapy. How SQAP affects internal radiotherapy, however, is not known. Here, we investigated the effects of SQAP for radioimmunotherapy (RIT) targeting tissue factor (TF) in a stroma-rich pancreatic cancer mouse model, BxPC-3. A low dose of SQAP (2 mg/kg) increased tumor uptake of the 111In-labeled anti-TF antibody 1849, indicating increased tumor perfusion. The addition of SQAP enhanced the growth-inhibitory effect of 90Y-labeled 1849 without leading to severe body weight changes, allowing for the dose of 90Y-labeled 1849 to be reduced to half that when used alone. Histologic analysis revealed few necrotic and apoptotic cells, but Ki-67–positive proliferating cells and increased vascular formation were detected. These results suggest that the addition of a low dose of SQAP may improve the therapeutic efficacy of TF-targeted RIT by increasing tumor perfusion, even for stroma-rich refractory pancreatic cancer. | |||||
書誌情報 |
Translational Oncology 巻 15, 号 1, p. 101285, 発行日 2022-01 |
|||||
出版者 | ||||||
出版者 | Elsevier | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1936-5233 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 34839108 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.tranon.2021.101285 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.sciencedirect.com/science/article/pii/S193652332100276X?via%3Dihub |